Welcome to our dedicated page for AKSO HEALTH GROUP news (Ticker: AHG), a resource for investors and traders seeking the latest updates and insights on AKSO HEALTH GROUP stock.
Akso Health Group (NASDAQ: AHG) combines social e-commerce innovation with AI-driven healthcare solutions, serving global markets through medical device distribution and digital health services. This dedicated news hub provides investors with essential updates on corporate developments, financial disclosures, and technological advancements.
Access real-time updates on earnings reports, strategic partnerships, regulatory milestones, and AI implementation progress. Our curated collection helps stakeholders track AHG's unique position at the intersection of healthcare technology and e-commerce logistics.
Key coverage areas include medical device market expansions, telemedicine service launches, and deep learning applications in diagnostic systems. Bookmark this page for verified updates directly from corporate communications and trusted financial analysis sources.
Akso Health Group (NASDAQ: AHG) announced the integration of DeepSeek's artificial intelligence technology to enhance its healthcare services. The company will utilize DeepSeek's multimodal large-scale models, deep learning frameworks, and big data processing capabilities to upgrade its AI-powered diagnosis system.
The enhanced system will integrate patient text descriptions, medical imaging, and laboratory test results to provide more accurate diagnoses and personalized treatment recommendations. AHG is also developing an AI-powered medical assistant to support doctors in retrieving patient records, analyzing similar cases, and recommending treatment plans.
The company focuses on implementing human-centric AI interactions to ensure a more natural and empathetic user experience, aiming to reduce patient anxiety and optimize consultation experiences. AHG plans to continue exploring AI applications in research and development, health management, and telemedicine.
Akso Health Group (NASDAQ: AHG) announced it received a notification from Nasdaq on February 28, 2023, indicating it is non-compliant with the minimum stockholders' equity requirement of $10 million. As of September 30, 2022, Akso reported approximately $9.9 million in stockholders' equity. While this notification does not immediately affect its listing, Akso has until April 14, 2023, to propose a compliance plan. If accepted, Nasdaq may grant an extension of up to 180 days, extending the compliance deadline to August 27, 2023.
Akso continues to operate within the social e-commerce and healthcare equipment sectors, previously known as Xiaobai Maimai.
Akso Health Group (NASDAQ: AHG) announced that it received a notification from Nasdaq regarding non-compliance with the minimum bid price requirement of US$1.00 per share, effective from October 26, 2022. The company's shares had fallen below this threshold for 30 consecutive business days. Akso Health has until April 24, 2023, to regain compliance. The company is exploring options like a reverse share split but asserts that its business operations remain unaffected. Furthermore, Nasdaq accepted the company’s plan for compliance regarding the delinquent filing of its Annual Report on Form 20-F.
Akso Health Group (NASDAQ: AHG) announced it received a notification from Nasdaq on August 16, 2022, for not complying with timely filing requirements, as it has not filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2022. The Company has 60 days to address this deficiency or submit a plan to regain compliance by October 17, 2022. The notification does not affect the Company's business operations. Akso Health also plans to expand into cancer therapy services, including opening 100 radiation oncology centers in the U.S.
